ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
02 mars 2018 09h15 HE
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court
07 févr. 2018 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Feb. 07, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), recently announced the complaint filed by Steven J. Keough in a South Dakota Federal Court, has been dismissed without...
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
02 mars 2015 09h17 HE
|
ViaDerma Licensing
LOS ANGELES, March 2, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start...
ViaDerma, Inc. Announces Preston Richards to Join Advisory Board
22 janv. 2015 09h01 HE
|
ViaDerma Licensing
LOS ANGELES, Jan. 22, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a developer of advanced topical pharmaceuticals, is pleased to announce the addition of Preston Richards to their Advisory...
ViaDerma, Inc. Launches New Website
13 janv. 2015 09h01 HE
|
ViaDerma Licensing
LOS ANGELES, Jan. 13, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to the market, is excited to officially announce its new...
TetraStem(TM) Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies
09 déc. 2014 09h44 HE
|
ViaDerma Licensing
LOS ANGELES, Dec. 9, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced TetraStemTM, a topical liquid...
ViaDerma, Inc. Lead Product TetraStem Shows Promise in Treating Acne
21 nov. 2014 10h16 HE
|
ViaDerma Licensing
LOS ANGELES, Nov. 21, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new...
ViaDerma, Inc. Appoints Dr. Andrew Berman as Medical Director of Advisory Board
13 nov. 2014 11h26 HE
|
ViaDerma Licensing
LOS ANGELES, Nov. 13, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, is pleased to announce the appointment of Dr....
TetraStem, Lead Product of ViaDerma, Inc., Hopes to Slow Rates of Diabetic Amputations
07 nov. 2014 08h54 HE
|
ViaDerma Licensing
LOS ANGELES, Nov. 7, 2014 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new...